top of page
XenoTherapeutics Candidates
in Clinical Trials
Our pipeline includes multiple biotherapeutic products in varying stages of development. Our lead biotherapeutic product, realSKIN , is currently preparing for a pivotal Phase 3 clinical trial for severe burns and has concluded preclinical work for realNERVE™ in peripheral nerve repair with a corresponding IND in process.
®


Learn more about the clinical program on clinicaltrials.gov

realSKIN is living skin that replaces damaged or severely burned skin to allow the patient to heal on their own; requiring fewer surgeries and faster healing.
®
bottom of page